Related Experiment Video
Updated: May 31, 2026

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection
Published on: February 10, 2017
Prevention of adhesion after endoscopic sinus surgery: role of mitomycin C
Mohammad-Hossein Baradaranfar1, Jalal Khadem, Shokooh Taghipoor Zahir
1Department of Otolaryngology, Head and Neck Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. baradaranf@yahoo.com
Abstract:
Adhesions after endoscopic sinus surgery (ESS) are a potential cause of surgical failure. Mitomycin-C (MMC) is recently proposed as a solution for these adhesions. This study was performed to investigate the effect of Mitomycin C in reducing scar formation and adhesion in the nasal mucosa after endoscopic nasal surgery. This double blind randomized clinical trial study was performed on 37 patients with bilateral chronic rhinosinusitis. At the end of ESS, randomly impregnated mesh with MMC was placed in one side and another mesh impregnated with saline in the opposite side for 5 minutes. Patients were followed at least for three months, and the results of diagnostic endoscopy were recorded. Post operative adhesion occurred in 12 (32.4%) patients (2 bilateral/10 unilateral). Among total of 14 adhesions, 4 (10.8%) were in the MMC side and 10 (27%) in the control side. This differences was close to statistically significant (P=0.058). MMC may reduce adhesions after ESS, but further studies with different doses, sample size and frequent use of topical MMC is recommended.
Insights
Mitomycin C (MMC) may reduce nasal adhesions after endoscopic sinus surgery (ESS). This study found fewer adhesions on the MMC-treated side, though results approached statistical significance, warranting further investigation.
Area of Science:
- Otolaryngology
- Surgical Innovation
- Wound Healing Research
Background:
- Post-surgical adhesions are a common complication following endoscopic sinus surgery (ESS).
- These adhesions can lead to surgical failure and negatively impact patient outcomes.
- Mitomycin C (MMC) has emerged as a potential therapeutic agent to mitigate adhesion formation.
Purpose of the Study:
- To evaluate the efficacy of Mitomycin C (MMC) in minimizing scar tissue and adhesion formation in the nasal mucosa post-ESS.
- To compare the incidence of adhesions between MMC-treated and saline-treated nasal sites.
Main Methods:
- A double-blind, randomized clinical trial involving 37 patients with bilateral chronic rhinosinusitis.
- Following ESS, randomly assigned nasal sides received either MMC-impregnated or saline-impregnated mesh for 5 minutes.
- Patients underwent diagnostic endoscopy follow-up for at least three months.
Main Results:
- Postoperative adhesions occurred in 12 (32.4%) patients.
- A total of 14 adhesions were observed: 4 (10.8%) on the MMC side and 10 (27%) on the control (saline) side.
- The observed difference in adhesion rates approached statistical significance (P=0.058).
Conclusions:
- Mitomycin C (MMC) shows potential in reducing adhesions after endoscopic sinus surgery (ESS).
- Further research with varied MMC dosages, larger sample sizes, and more frequent topical application is recommended to confirm efficacy.
Related Concept Videos
Suctioning the Nasopharyngeal Airway
Equipment Required
Tonsillitis II: Management

